News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

|Articles|August 1, 2013

How RBM Impacts the Way Sanofi Handles Monitoring

Lori Convy, assistant director clinical research monitoring, Sanofi discusses risk-based monitoring

Lori Convy, assistant director clinical research monitoring, Sanofi discusses risk-based monitoring.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

dashClinical: Real-Time Participant Payments

ByKatie Anne Oden

October 27th 2025

AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions

ByGen Li, PhD, MBA,Andy Studna, Senior Editor

October 27th 2025

ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms

ByAndy Studna, Senior Editor

October 27th 2025

Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models

ByGen Li, PhD, MBA,Andy Studna, Senior Editor

October 24th 2025

© Shuo - © Shuo - stock.adobe.com

Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences

ByAndy Studna, Senior Editor

October 24th 2025

Trending on Applied Clinical Trials Online

ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms

dashClinical: Real-Time Participant Payments

AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions

© 2025 MJH Life Sciences^®

All rights reserved.